Stay updated with breaking news from Juan Fu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
<p>Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients’ immune systems fight back against cancer, according to a study by investigators at the <a href="https://www.hopkinsmedicine.org/kimmel-cancer-center">Johns Hopkins Kimmel Cancer Center</a> and its <a href="https://www.hopkinsmedicine.org/kimmel-cancer-center/bloomberg-kimmel-institute-for-cancer-immunotherapy">Bloomberg~Kimmel Institute for Cancer Immunotherapy</a><u>.</u></p...